Hologic's HPV high-risk test approved for use in The Netherlands

RELATED QUOTES

SymbolPriceChange
HOLX21.22

Hologic announced that the NVVP, or Netherlands Society for Pathology, has approved the use of the Hologic Cervista HPV HR test for detecting human papillomavirus in the Dutch national cervical screening program.

  •  
    Recent Quotes
    Symbol Price Change % ChgChart 
    Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.
    You need to enable your browser cookies to view your most recent quotes.
  • Recent Quotes News

    •  
      Sign-in to view quotes in your portfolios.

    Trading Center

    Yahoo! Finance on Facebook

    POLL

    Do you trust the IRS in light of its recent scandals?

    Loading...
    Poll Choice Options